XTX Topco Ltd Makes New Investment in Ocular Therapeutix, Inc. (NASDAQ:OCUL)
XTX Topco Ltd bought a new stake in Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 11,593 shares of the biopharmaceutical company’s stock, valued at approximately $99,000. Several other hedge funds have also bought and sold shares of OCUL. […]
XTX Topco Ltd bought a new stake in Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 11,593 shares of the biopharmaceutical company’s stock, valued at approximately $99,000. Several other hedge funds have also bought and sold shares of OCUL. […]
